Nestlé raises $28bn from Alcon stake

Nestlé secured a multi-billion dollar boost today after selling its stake in an eye care firm it acquired for $280m (€195m) in 1977.

The agreement to sell the remaining 52% holding in Alcon to healthcare firm Novartis is expected to raise $28.1bn (€19.6bn).